Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Transformation Hurdles | Avanos Medical faces challenges in its three-year plan, with mixed segment performance and leadership changes impacting its strategic direction |
Financial Landscape | Despite revenue shortfalls, Avanos maintains profitability and liquidity. Analysts project growth, with price targets reflecting cautious optimism |
Segment Dynamics | Explore the contrasting fortunes of Avanos' business units: Digestive Health's robust growth versus Pain Management's persistent volatility |
Future Trajectory | Delve into Avanos' ambitious 2025 targets, including margin expansion and free cash flow goals, amidst ongoing transformation efforts |
Metrics to compare | AVNS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVNSPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.7x | −12.8x | −0.5x | |
PEG Ratio | 0.00 | −0.31 | 0.00 | |
Price/Book | 0.8x | 7.9x | 2.6x | |
Price / LTM Sales | 1.0x | 3.8x | 3.0x | |
Upside (Analyst Target) | 17.6% | 57.6% | 56.6% | |
Fair Value Upside | Unlock | −13.9% | 10.1% | Unlock |